First, we used hNucleoli, CK19, and pan-cytokeratin to confirm that the tumors formed were derived from injected human pancreatic cancer cells and, using VIM, that CAFs were present in the CIPCO-injected group (Figure 3B). This evidence concerns the gene KRT19 and pancreatic neoplasm.